Startup Funding News
Explore funding rounds, the companies behind them and the investors taking part.
- Rounds
- 4,727 Jan 1 – Oct 24, 2026
- Disclosed funding
- $306.4B 3683 disclosed amounts
- Median round
- $14.6M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| U URALAACompany profile URALAA develops immersive live entertainment that brings sports, music and other events into shared viewing spaces. URALAA develops immersive live entertainment that brings sports, music and other events into shared viewing spaces. | ¥210M | Pre-Series ASeed | Media & gaming | Japan | Investors | |
| x Transforms fragmented medical records into decision-ready data | $46M | Series B | Healthtech | United States | Investors | |
| KT Kotoba TechnologiesCompany profile Develops real-time speech models optimized for East Asian languages for agents, devices, and translation Develops real-time speech models optimized for East Asian languages for agents, devices, and translation | $10M | Seed+Seed | AI | United States | Investors | |
| Z Develops an AI-native learning system for lifecycle marketing | €3M | Pre-SeedPre-seed | Enterprise software | Germany | Investors | |
| AH Assort HealthCompany profile Provides AI-powered patient journey platform for healthcare organizations Provides AI-powered patient journey platform for healthcare organizations | $120M | Series CSeries C+ | Healthtech | United States | Investors | |
| C Develops AI-powered procurement software for industrial companies | €3.2M | Seed | Enterprise software | Italy | Investors | |
| L Develops lab plastic recycling system | £430K | Seed | Climate tech | United Kingdom | Investors | |
| OC Develops software to optimise and compress AI foundation models | €3.5M | Seed | AI | Austria | Investors | |
| OB Ollin BiosciencesCompany profile Develops bispecific antibody therapies for retinal vascular diseases including diabetic macular edema and wet AMD Develops bispecific antibody therapies for retinal vascular diseases including diabetic macular edema and wet AMD | $330M | Series B | Biotech | United States | Investors | |
| AD ARCYN DefenseCompany profile Develops kinetic energy system to counter unmanned aerial systems and other airborne threats Develops kinetic energy system to counter unmanned aerial systems and other airborne threats | Undisclosed | Seed+Seed | Defense tech | United States | Investors Undisclosed |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
BioStack, Tractian, Blacksmith
161rounds5led - 2Andreessen Horowitz (a16z)
ASI, Eka Robotics, Town
112rounds22led - 3General Catalyst
Tractian, Legora, Different
101rounds12led - 4Lightspeed
Warp Sciences, Different, Zenzap
80rounds9led - 5Sequoia Capital
Warhound, Whop, Blacksmith
72rounds13led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.
Browse rounds by topic
Geography
Featured selections
Nordic Foodtech Fund II pairs early capital with scientific expertise
An EIF pledge of up to €30m supports a fund targeting €80m for science-led agrifood companies.
Read the research →